Cargando…

CS15-04 The Role of Polo-like Kinase 1 as a Therapeutic Target in Hepatocellular Carcinoma

Detalles Bibliográficos
Autor principal:	Lim, Seng-Gee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society for Infectious Diseases. Published by Elsevier Ltd. 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128852/ http://dx.doi.org/10.1016/S1201-9712(09)60305-2

Ejemplares similares

Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis
por: Liu, Lili, et al.
Publicado: (2012)

High Expression of Polo-Like Kinase 1 Is Associated with Early Development of Hepatocellular Carcinoma
por: Sun, Wei, et al.
Publicado: (2014)

Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment()
por: Liu, Xiaoqi
Publicado: (2015)

Identification of polo‐like kinase 1 as a therapeutic target in murine lupus
por: Li, Yaxi, et al.
Publicado: (2022)

Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2021)

Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1
por: Yun, Sang-Moon, et al.
Publicado: (2009)

Polo-like kinase 1 as target for cancer therapy
por: Weiß, Lily, et al.
Publicado: (2012)

Therapeutic inhibition of polo‐like kinases in anaplastic thyroid cancer
por: Lin, Shu‐Fu, et al.
Publicado: (2021)

Polo-like kinase in trypanosomes: an odd member out of the Polo family
por: Kurasawa, Yasuhiro, et al.
Publicado: (2020)

Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma
por: Amani, Vladimir, et al.
Publicado: (2016)

Putting a bit into the polo-box domain of polo-like kinase 1
por: Park, Jung-Eun, et al.
Publicado: (2015)

Role for polo-like kinase 4 in mediation of cytokinesis
por: Press, Michael F., et al.
Publicado: (2019)

Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma
por: Bussey, Kimberly J., et al.
Publicado: (2016)

Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma
por: Li, Yan, et al.
Publicado: (2020)

Polo-Like Kinase 1(PLK1) Immunohistochemical Expression in Triple Negative Breast Carcinoma: A Probable Therapeutic Target
por: Salama, Maha E, et al.
Publicado: (2021)

The balance of Polo-like kinase 1 in tumorigenesis
por: Lu, Lin-Yu, et al.
Publicado: (2009)

The CINs of Polo-Like Kinase 1 in Cancer
por: Cunningham, Chelsea E., et al.
Publicado: (2020)

Roles of Polo-like kinase 3 in suppressing tumor angiogenesis
por: Xu, Dazhong, et al.
Publicado: (2012)

Design and Synthesis of a Cell-Permeable, Drug-Like Small Molecule Inhibitor Targeting the Polo-Box Domain of Polo-Like Kinase 1
por: Srinivasrao, Ganipisetti, et al.
Publicado: (2014)

Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma
por: Weichert, W, et al.
Publicado: (2004)

Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma
por: Ito, Y, et al.
Publicado: (2004)

Computational Design of Targeted Inhibitors of Polo-Like Kinase 1 (Plk1)
por: Jani, Krupa S., et al.
Publicado: (2012)

The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
por: de Cárcer, Guillermo
Publicado: (2019)

Spatial and temporal control of targeting Polo-like kinase during meiotic prophase
por: Brandt, James N., et al.
Publicado: (2020)

Targeting Polo-like kinase in space and time during C. elegans meiosis
por: Brandt, James N., et al.
Publicado: (2021)

Polo-like kinase-1 in DNA damage response
por: Hyun, Sun-Yi, et al.
Publicado: (2014)

Playing POLO-like kinase in NRAS mutant melanoma
por: Chen, Hsin-Yi, et al.
Publicado: (2015)

Polo-Like Kinase 2: From Principle to Practice
por: Zhang, Chuanyong, et al.
Publicado: (2022)

Polo-like kinase 1 promotes pulmonary hypertension
por: Chen, Rongrong, et al.
Publicado: (2023)

A selective inhibitor of the Polo-box domain of Polo-like kinase 1 identified by virtual screening
por: Abdelfatah, Sara, et al.
Publicado: (2018)

Autophosphorylation of Polo-like Kinase 4 and Its Role in Centriole Duplication
por: Sillibourne, James E., et al.
Publicado: (2010)

Potential Tumor Suppressor Role of Polo-like Kinase 5 in Cancer
por: Su, Shengqin, et al.
Publicado: (2023)

The MicroRNA3686 Inhibits the Proliferation of Pancreas Carcinoma Cell Line by Targeting the Polo-Like Kinase 1
por: Jin, Hong-Yi, et al.
Publicado: (2015)

The mitotic regulator polo‐like kinase 1 as a potential therapeutic target for c‐Myc‐overexpressing canine osteosarcomas
por: Gola, Cecilia, et al.
Publicado: (2022)

Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agents
por: Park, Jung-Eun, et al.
Publicado: (2017)

Identification of Polo-like kinases as potential novel drug targets for influenza A virus
por: Pohl, Marie O., et al.
Publicado: (2017)

Modulating Protein-Protein Interactions of the Mitotic Polo-like Kinases to Target Mutant KRAS
por: Narvaez, Ana J., et al.
Publicado: (2017)

Development of ultra-high affinity bivalent ligands targeting the polo-like kinase 1
por: Tsuji, Kohei, et al.
Publicado: (2022)

Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors
por: Nieto-Jiménez, Cristina, et al.
Publicado: (2017)

Exploring the Binding Nature of Pyrrolidine Pocket-Dependent Interactions in the Polo-Box Domain of Polo-Like Kinase 1
por: Murugan, Ravichandran N., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j8atl5d8m8d4mct390j9gjcdta